| Brain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer's disease in the presenilin 1 E280A kindred: a case-control study EM Reiman, YT Quiroz, AS Fleisher, K Chen, C Velez-Pardo, ... The Lancet Neurology 11 (12), 1048-1056, 2012 | 606 | 2012 |
| A gain-of-function mutation in TRPA1 causes familial episodic pain syndrome Neuron 66 (5), 671-80, 2010 | 514 | 2010 |
| Symptom onset in autosomal dominant Alzheimer disease: a systematic review and meta-analysis DC Ryman, N Acosta-Baena, PS Aisen, T Bird, A Danek, NC Fox, A Goate, ... Neurology 83 (3), 253-260, 2014 | 512 | 2014 |
| Pre-dementia clinical stages in presenilin 1 E280A familial early-onset Alzheimer's disease: a retrospective cohort study N Acosta-Baena, D Sepulveda-Falla, CM Lopera-Gómez, ... The Lancet Neurology 10 (3), 213-220, 2011 | 282 | 2011 |
| Florbetapir PET analysis of amyloid-β deposition in the presenilin 1 E280A autosomal dominant Alzheimer's disease kindred: a cross-sectional study AS Fleisher, K Chen, YT Quiroz, LJ Jakimovich, MG Gomez, CM Langois, ... The Lancet Neurology 11 (12), 1057-1065, 2012 | 273 | 2012 |
| Associations between biomarkers and age in the presenilin 1 E280A autosomal dominant Alzheimer disease kindred: a cross-sectional study AS Fleisher, K Chen, YT Quiroz, LJ Jakimovich, MG Gomez, CM Langois, ... JAMA neurology 72 (3), 316-324, 2015 | 190 | 2015 |
| Brain imaging and blood biomarker abnormalities in children with autosomal dominant Alzheimer disease: a cross-sectional study YT Quiroz, AP Schultz, K Chen, HD Protas, M Brickhouse, AS Fleisher, ... JAMA neurology 72 (8), 912-919, 2015 | 121 | 2015 |
| The Alzheimer's Prevention Initiative Autosomal-Dominant Alzheimer's Disease Trial: A study of crenezumab versus placebo in preclinical PSEN1 E280A mutation carriers to … PN Tariot, F Lopera, JB Langbaum, RG Thomas, S Hendrix, LS Schneider, ... Alzheimer's & Dementia: Translational Research & Clinical Interventions 4 …, 2018 | 114 | 2018 |
| The Alzheimer's prevention initiative composite cognitive test score: sample size estimates for the evaluation of preclinical Alzheimer's disease treatments in presenilin 1 … N Ayutyanont, JBS Langbaum, SB Hendrix, K Chen, AS Fleisher, ... The Journal of clinical psychiatry 75 (6), 727, 2014 | 99 | 2014 |
| Pooling/bootstrap-based GWAS (pbGWAS) identifies new loci modifying the age of onset in PSEN1 p. Glu280Ala Alzheimer's disease JI Vélez, SC Chandrasekharappa, E Henao, AF Martinez, U Harper, ... Molecular psychiatry 18 (5), 568-575, 2013 | 53 | 2013 |
| Trajectory of unawareness of memory decline in individuals with autosomal dominant Alzheimer disease P Vannini, BJ Hanseeuw, JR Gatchel, SAM Sikkes, D Alzate, Y Zuluaga, ... JAMA network open 3 (12), e2027472-e2027472, 2020 | 28 | 2020 |
| The Colombian Alzheimer's Prevention Initiative (API) Registry S Rios‐Romenets, H Lopez, L Lopez, L Hincapie, A Saldarriaga, ... Alzheimer's & Dementia 13 (5), 602-605, 2017 | 22 | 2017 |
| Normative data stratified by age and education for a Spanish neuropsychological test battery: Results from the Colombian Alzheimer’s prevention initiative registry VL Torres, C Vila-Castelar, Y Bocanegra, A Baena, E Guzmán-Vélez, ... Applied Neuropsychology: Adult 28 (2), 230-244, 2021 | 18 | 2021 |
| Baseline demographic, clinical, and cognitive characteristics of the Alzheimer's Prevention Initiative (API) Autosomal‐Dominant Alzheimer's Disease Colombia Trial S Rios‐Romenets, F Lopera, KM Sink, N Hu, Q Lian, H Guthrie, J Smith, ... Alzheimer's & Dementia 16 (7), 1023-1030, 2020 | 16 | 2020 |
| Alzheimer’s Prevention Initiative. The Alzheimer’s Prevention Initiative Autosomal-Dominant Alzheimer’s Disease Trial: A study of crenezumab versus placebo in preclinical PSEN1 … PN Tariot, F Lopera, JB Langbaum, RG Thomas, S Hendrix, LS Schneider, ... Alzheimers Dement (NY) 4, 150-160, 2018 | 15 | 2018 |
| Examining sex differences in markers of cognition and neurodegeneration in autosomal dominant Alzheimer’s disease: Preliminary findings from the Colombian Alzheimer’s … C Vila-Castelar, E Guzmán-Vélez, E Pardilla-Delgado, RF Buckley, ... Journal of Alzheimer's Disease 77 (4), 1743-1753, 2020 | 13 | 2020 |
| Analysis of family stigma and socioeconomic factors impact among caregivers of patients with early-and late-onset Alzheimer's disease and frontotemporal dementia L Velilla, N Acosta-Baena, I Allen, F Lopera, J Kramer Scientific reports 12 (1), 12663, 2022 | 12 | 2022 |
| Sex differences in cognitive resilience in preclinical autosomal‐dominant Alzheimer's disease carriers and non‐carriers: baseline findings from the API ADAD Colombia Trial C Vila‐Castelar, PN Tariot, KM Sink, D Clayton, JB Langbaum, ... Alzheimer's & Dementia 18 (11), 2272-2282, 2022 | 11 | 2022 |
| PET evidence of preclinical cerebellar amyloid plaque deposition in autosomal dominant Alzheimer’s disease-causing Presenilin-1 E280A mutation carriers V Ghisays, F Lopera, DD Goradia, HD Protas, MH Malek-Ahmadi, Y Chen, ... NeuroImage: Clinical 31, 102749, 2021 | 9 | 2021 |
| Novel cerebrotendinous xanthomatosis mutation causes familial early dementia in Colombia M Giraldo-Chica, N Acosta-Baena, L Urbano, L Velilla, F Lopera, ... Biomédica 35 (4), 563-571, 2015 | 9 | 2015 |
Francisco LoperaFull Professor of University of AntioquiaAdresse e-mail validée de gna.org.co
